7Fulton B, Spencer CM. Docetaxel: A review of itspharmacodynamic and pharmacokinetic properties and therapeutic eficacy in the management of metastatic breast cancer[J]. Drugs, 1996, 51(6): 1 075.
8Dieras V, Guastalla J P, Ferrero JM, et al. A multicenter phase Ⅱ study of cisplatin and docetaxel (Taxotere) in the first-line treatment of advanced ovarian cancer:a GINECO study[J]. Cancer Chem Ther Pharmaco, 2004, 53 (6) : 489.
